My Legacy Advisors LLC Lowers Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

My Legacy Advisors LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,602 shares of the company’s stock after selling 40 shares during the quarter. My Legacy Advisors LLC’s holdings in HCA Healthcare were worth $1,245,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the business. CX Institutional raised its stake in shares of HCA Healthcare by 32.0% during the first quarter. CX Institutional now owns 20,726 shares of the company’s stock worth $7,162,000 after acquiring an additional 5,019 shares in the last quarter. MV Capital Management Inc. grew its holdings in shares of HCA Healthcare by 31.8% in the first quarter. MV Capital Management Inc. now owns 199 shares of the company’s stock worth $69,000 after purchasing an additional 48 shares during the last quarter. Integrated Advisors Network LLC grew its holdings in shares of HCA Healthcare by 17.7% in the first quarter. Integrated Advisors Network LLC now owns 5,768 shares of the company’s stock worth $1,993,000 after purchasing an additional 869 shares during the last quarter. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare in the first quarter worth approximately $28,000. Finally, SG Americas Securities LLC boosted its holdings in shares of HCA Healthcare by 1,405.0% during the 1st quarter. SG Americas Securities LLC now owns 7,194 shares of the company’s stock valued at $2,486,000 after buying an additional 6,716 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Down 2.2%

HCA stock opened at $364.79 on Wednesday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market capitalization of $87.76 billion, a price-to-earnings ratio of 16.60, a PEG ratio of 1.10 and a beta of 1.49. The business has a 50 day simple moving average of $356.11 and a two-hundred day simple moving average of $332.28.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion for the quarter, compared to analysts’ expectations of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same period in the prior year, the firm earned $5.36 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.79%. HCA Healthcare’s dividend payout ratio (DPR) is 12.81%.

Insider Activity at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the sale, the chief operating officer now owns 12,646 shares in the company, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.30% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Robert W. Baird restated a “neutral” rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Stephens upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Monday, June 2nd. Royal Bank of Canada dropped their target price on shares of HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating on the stock in a report on Monday, April 28th. Baird R W lowered HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Finally, Wells Fargo & Company upgraded HCA Healthcare from an “underweight” rating to an “equal weight” rating and boosted their price objective for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $392.47.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.